Alstom gets vaccine boost as it launches rights issue
Alstom, the French manufacturer of trains, trams and buses, has embarked upon its long-awaited rights issue with a fair wind behind it after the recent progress towards a Covid-19 vaccine.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: